The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter 
Professionals >> Visit The Body PROThe Body en Espanol
  • Email Email
  • Glossary Glossary

Atripla (Efavirenz/Tenofovir/FTC)

The Details

Atripla (efavirenz/tenofovir/emtricitabine or EFV/TDF/FTC) is a multi-class combination drug used to treat HIV/AIDS. It is approved by the U.S. FDA for the treatment of HIV infection in adults and children 12 years of age and older. It is listed in the HHS HIV treatment guidelines as an alternative regimen for people starting HIV treatment for the first time.


Adult single dose: Take one tablet once daily. Each tablet contains 600 mg of efavirenz, 300 mg of tenofovir and 200 mg of emtricitabine.


  • Take orally on an empty stomach, preferably at bedtime.
  • Not recommended for patients with moderate or severe hepatic impairment.
  • Pregnant women should not take Atripla.
  • Women should not breastfeed while on Atripla.
The Basics

  • Email Email
  • Glossary Glossary

The content on this page is free of advertiser influence and was produced by our editorial team. See our advertising policy.